Lobbying Activity Report

138-44060

Organization: Amgen Canada Inc.
Associated registration: 8948-138-36
Lobbying Activity date: 2025-06-20
Arranged a meeting: No
Posted date: 2025-07-14

In-house lobbyists who participated in the lobbying activity: Nathan Michaels
Senior Public Office Holders who were lobbied in this activity: Reah Arora, MLA for Burnaby East
Member(s) of the BC Legislative Assembly
 
Subject Matter of the Lobbying Activity
Specific Topics of Lobbying Communications Intended Outcomes Associated Subject Matters
Communicating with government officials, in general, about the pharmaceutical sector in British Columbia. The goal of these communications is (i) to keep the provincial government informed of general industry developments, initiatives and trends and (ii) to explore potential collaboration, in general, between industry and the provincial government.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
Health, Science and Technology
Communicating with government officials about the listing of Amgen's products for reimbursement purposes on government formularies, including on the BC PharmaCare Formulary.
  • Development, establishment, amendment or termination of any program, policy, directive or guideline of the government of British Columbia or a Provincial entity
  • Awarding, amendment or termination of any contract, grant or financial benefit by or on behalf of the government of British Columbia or a Provincial entity
Health
 
Senior officer who filed this Lobbying Activity Report: Ugur Gunaydin
 
The above name is that of the most senior paid officer who is responsible for filing a Lobbying Activity Report for the organization (the Designated Filer), whether that person participated in this lobbying activity or not.

Return to Registration for Canadian Institute for Advanced Research (CIFAR)
Date Modified: